Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Return on Capital Employed (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Return on Capital Employed for 4 consecutive years, with 1.88% as the latest value for Q3 2020.

  • Quarterly Return on Capital Employed fell 85.0% to 1.88% in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 1.88% through Sep 2020, down 85.0% year-over-year, with the annual reading at 0.08% for FY2019, 49.0% up from the prior year.
  • Return on Capital Employed for Q3 2020 was 1.88% at Forte Biosciences, up from 1.95% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.39% in Q3 2017, with the low at 9.67% in Q1 2020.
  • Average Return on Capital Employed over 4 years is 1.45%, with a median of 0.6% recorded in 2019.
  • The sharpest move saw Return on Capital Employed surged 113bps in 2018, then crashed -907bps in 2020.
  • Over 4 years, Return on Capital Employed stood at 0.47% in 2017, then dropped by -21bps to 0.57% in 2018, then increased by 7bps to 0.53% in 2019, then tumbled by -254bps to 1.88% in 2020.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 1.88%, 1.95%, and 9.67% for Q3 2020, Q2 2020, and Q1 2020 respectively.